GAM
BIVV

Gemmer Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Gemmer Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-115
Closed -$6K – 1531
2017
Q4 		$6K Sell
115
-43
-27% -$2.35K ﹤0.01% 939
2017
Q3 		$9K Buy
158
+46
+41% +$2.69K ﹤0.01% 748
2017
Q2 		$7K Buy
112
+18
+19% +$1.02K ﹤0.01% 824
2017
Q1 		$5K Buy
+94
New +$4.63K ﹤0.01% 951

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Gemmer Asset Management's BIVV Position: Q1 2018 in Review

Gemmer Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 115 shares — an estimated $6K sold.

Gemmer Asset Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $9K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Gemmer Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Gemmer Asset Management sold 115 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $6K.
  • Gemmer Asset Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Gemmer Asset Management's Bioverativ Inc. Common Stock position peaked at $9K in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Gemmer Asset Management's 13F filing for Q1 2018, filed 11 May 2018.